|
Summary Information: Bellicum Pharmaceuticals Inc. Common Stock NASDAQ:BLCM |
  admin@troach.net |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Bellicum is a clinical stage biopharmaceutical company striving to deliver cures through controllable cell therapies. The company's next-generation product candidates are differentiated by powerful cell signaling technologies designed to produce more effective CAR-T cell therapies. Bellicum's GoCAR-T® product candidates, BPX-601 and BPX-603, are designed to be more efficacious CAR-T cell products capable of overriding key immune inhibitory mechanisms.
__The following are links to various summary and news pages for __Bellicum Pharmaceuticals Inc. Common Stock [ BLCM ]. __Note: Some Links might not have information for the company. |
|